Previous Article | Next Article 
J Virol, May 1998, p. 4352-4363, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2:
Lessons from the Study of a T-Cell-Immunocompromised Hemophilic
Cohort
Q. Y.
Yao,1
D. S. G.
Croom-Carter,1
R. J.
Tierney,1
G.
Habeshaw,1
J. T.
Wilde,2
F. G. H.
Hill,3
C.
Conlon,4 and
A.
B.
Rickinson1,*
CRC Institute for Cancer Studies, University
of Birmingham, Edgbaston, Birmingham B15 2TA,1
Department of Haematology, University Hospital Trust,
Edgbaston, Birmingham B15 2TH,2
Department of Haematology, Birmingham Children's Hospital,
Ladywood, Birmingham B16 8ET,3 and
Nuffield Department of Medicine, John Radcliffe Hospital,
Headington, Oxford OX3 9DU,4 United Kingdom
Received 17 November 1997/Accepted 4 February 1998
In apparent contrast to earlier work on Epstein-Barr virus (EBV)
carriage in the general Caucasian population, in vitro virus isolations
from human immunodeficiency virus (HIV)-positive male homosexual
cohorts have shown frequent examples of multiple EBV infection and an
overall prevalence of type 2 EBV strains exceeding 30%. Here we ask to
what extent these findings might hold true in another
T-cell-immunocompromised cohort, HIV-positive hemophilic patients.
Resident EBV strains were rescued within lymphoblastoid cell lines
derived from the blood and throat washings of 39 such individuals,
using the same in vitro protocols of virus isolation as for the
homosexual cohort. A mean of 19 independent cell lines was made per
patient, and in each case the resident virus was characterized by
PCR-based viral genomic analysis and by immunoblotting to reveal the
viral "EBNAprint." By these criteria a significant proportion (14 of 39) of the hemophilic cohort carried more than one EBV strain,
suggesting that T-cell impairment does indeed sensitize virus carriers
to reinfection with new strains of exogenously transmitted virus.
However, the overall incidence of type 2 EBV infection was 10%, which
is close to that observed in the earlier work with healthy carriers and
substantially lower than that seen in HIV-positive homosexuals. We
infer that type 2 EBV is relatively rare in the general Caucasian
population but has become endemic in the homosexual community.
*
Corresponding author. Mailing address: CRC Institute
for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TA, United Kingdom. Phone: 121-414-4492. Fax: 121-414-4486. E-mail: Williamsd{at}cancer.bham.ac.uk.
J Virol, May 1998, p. 4352-4363, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Harada, S., Kamata, Y., Ishii, Y., Eda, H., Kitamura, R., Obayashi, M., Ito, S., Ban, F., Kuranari, J., Nakajima, H., Kuze, T., Hayashi, M., Okabe, N., Senpuku, H., Miyasaka, N., Nakamura, Y., Kanegane, H., Yanagi, K.
(2004). Maintenance of Serum Immunoglobulin G Antibodies to Epstein-Barr Virus (EBV) Nuclear Antigen 2 in Healthy Individuals from Different Age Groups in a Japanese Population with a High Childhood Incidence of Asymptomatic Primary EBV Infection. CVI
11: 123-130
[Abstract]
[Full Text]
-
Walling, D. M., Brown, A. L., Etienne, W., Keitel, W. A., Ling, P. D.
(2003). Multiple Epstein-Barr Virus Infections in Healthy Individuals. J. Virol.
77: 6546-6550
[Abstract]
[Full Text]
-
Tao, Q., Yang, J., Huang, H., Swinnen, L. J., Ambinder, R. F.
(2002). Conservation of Epstein-Barr Virus Cytotoxic T-Cell Epitopes in Posttransplant Lymphomas : Implications for Immune Therapy. Am. J. Pathol.
160: 1839-1845
[Abstract]
[Full Text]
-
Nikiforow, S., Bottomly, K., Miller, G.
(2001). CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation. J. Virol.
75: 3740-3752
[Abstract]
[Full Text]
-
Srivastava, G., Wong, K. Y., Chiang, A. K. S., Lam, K. Y., Tao, Q.
(2000). Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood
95: 2443-2445
[Abstract]
[Full Text]
-
Brooks, J. M., Croom-Carter, D. S. G., Leese, A. M., Tierney, R. J., Habeshaw, G., Rickinson, A. B.
(2000). Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains. J. Virol.
74: 1801-1809
[Abstract]
[Full Text]
-
Midgley, R. S., Blake, N. W., Yao, Q. Y., Croom-Carter, D., Cheung, S. T., Leung, S. F., Chan, A. T. C., Johnson, P. J., Huang, D., Rickinson, A. B., Lee, S. P.
(2000). Novel Intertypic Recombinants of Epstein-Barr Virus in the Chinese Population. J. Virol.
74: 1544-1548
[Abstract]
[Full Text]
-
Aguirre, A. J., Robertson, E. S.
(2000). Epstein-Barr Virus Recombinants from BC-1 and BC-2 Can Immortalize Human Primary B Lymphocytes with Different Levels of Efficiency and in the Absence of Coinfection by Kaposi's Sarcoma-Associated Herpesvirus. J. Virol.
74: 735-743
[Abstract]
[Full Text]
-
van Baarle, D., Hovenkamp, E., Kersten, M. J., Klein, M. R., Miedema, F., van Oers, M. H.J.
(1999). Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma. Blood
93: 3949-3955
[Abstract]
[Full Text]
-
Habeshaw, G., Yao, Q. Y., Bell, A. I., Morton, D., Rickinson, A. B.
(1999). Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt's Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas. J. Virol.
73: 965-975
[Abstract]
[Full Text]